(Q34997085)

5 August 2017

1 reference

title

Gemzar platinum combinations: phase III trials in non-small cell lung cancer (English)

1 reference

5 August 2017

main subject

phase III clinical trial

0 references

author name string

Lucio Crinò

series ordinal

1

1 reference

5 August 2017

Cesare Calandri

series ordinal

2

1 reference

5 August 2017

publication date

1 November 2002

1 reference

5 August 2017

1 reference

5 August 2017

volume

38 Suppl 2

1 reference

5 August 2017

page(s)

S9-12

1 reference

5 August 2017

cites work

Cancer statistics, 2000.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900351-3

7 January 2021

Estimates of the worldwide mortality from 25 cancers in 1990.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900351-3

7 January 2021

Novel chemotherapeutic agents in the treatment of non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900351-3

7 January 2021

Activity of gemcitabine in patients with non-small cell lung cancer: a multicentre, extended phase II study

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900351-3

7 January 2021

The influence of gemcitabine and cisplatin schedule on response and survival in advanced non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900351-3

7 January 2021

Phase III trial of gemcitabine plus cisplatin versus cisplatin alone in patients with locally advanced or metastatic non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900351-3

7 January 2021

Randomized phase III study of gemcitabine-cisplatin versus etoposide-cisplatin in the treatment of locally advanced or metastatic non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900351-3

7 January 2021

Gemcitabine and cisplatin versus mitomycin, ifosfamide, and cisplatin in advanced non-small-cell lung cancer: A randomized phase III study of the Italian Lung Cancer Project

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900351-3

7 January 2021

Platinum-based and non-platinum-based chemotherapy in advanced non-small-cell lung cancer: a randomised multicentre trial

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900351-3

7 January 2021

10.1016/S0169-5002(02)00351-3

Identifiers

DOI

1 reference

5 August 2017

1 reference